Pulseline

@{site-date-dd} @{site-date-month} @{site-date-yyyy}

Reform of Prostheses Benefits

The Department of Health has commenced work on a research and design project as a first stage in developing in benefit setting framework for prostheses.

 

The Project is being managed by the Department with guidance from the Prostheses List Advisory Committee. 

 

The Department has engaged the University of Melbourne’s Centre for Health Policy to research pricing models for medical devices and develop options for the design of frameworks for prostheses benefits within the Australian private health setting.

 

This project leads on from the Industry Working Group on Private Health Insurance Prostheses Reform and its final report, which set out a number of areas for improvement and potential change.  One such area is to create a more competitive basis for purchase and reimbursement of prostheses, including consideration of options for new pricing mechanisms.

 

What they are after is information on the current arrangements on supplying, purchasing and reimbursing medical devices, including the consideration of innovative approaches that may support:

1. a more competitive and value-for-money basis for purchasing and reimbursement;

2. improved transparency in benefit setting for a device, taking into consideration appropriate costs for inclusion in the benefit (eg. clinically relevant requirements, such as: in theatre assistance, software, maintenance, monitoring, and product support, etc.); and

3. timely access to a reasonable choice of prostheses.

The MTAA as a key stakeholder has been asked to provide insights that would benefit this research work.

 

Affected stakeholders and interested parties are invited to contribute to the project, by providing any views, comments and where possible evidence based data to help inform the project research.

 

The MTAA has agreed to compile feedback from our members to pass on to the research team. But we would like to extend this opportunity to non-MTAA PL companies as well to ensure we capture as much of the industry as possible.

 

We have set up a designated email address to assist with this task: PLreform@mtaa.org.au

 

Alternatively, or if you prefer not to submit to MTAA, you are welcome to submit comments directly to the Department by emailing prosthesesreform@health.gov.au

 

Please note all consultation responses from either peak bodies or individuals must be received by close of business 21 December 2016.

 

Andrea Kunca
MTAA Co-Lead

What's New?

Image

MTAA is excited to announce our improved website!
On Monday 21st the MTAA website was updated and ready for use. You should have received a welcome email with details on what you need to do including setting up a new password for the website.  If you are having any issues with the new website please contact webmaster@mtaa.org.au

 

We hope you find the new website easier to use; we will continue to work hard to make sure it contains valuable MedTech information to assist you with your needs. Thank you for your understanding (especially those whose email included an interesting translation of your name) during our transition and we look forward to your continued feedback.

Industry News

Image

Senate Inquiry into Prostheses List Framework

On Monday (21 November) as anticipated the Senate voted to support Senator Xenophon and Senator Griff motion for a Senate inquiry into the prostheses list to be undertaken by the Senate Community Affairs Committee.

 

The Government voted against the motion outlining the issue has extensively been examined, and continues to be a priority of the PLAC, therefore a separate Senate inquiry would duplicate work that has already been undertaken by the working group and may risk delaying much-needed reform.

 

Submissions should be received by 30 January 2017. The Committee has set a report date of 30 March 2017.

 

The Committee Secretariat and Committee Senators will make a recommendation of stakeholders it would like to hear from. They will then send a letter inviting people to lodge a submission. But anyone is free to make a submission.

 

Understandably lodging a submission increases the possibility of being called to appear before the Committee.

 

Once submissions close nothing will happen until Parliament resumes on 7 February 2017. The Committee will review submissions and will make a decision on who they will ask to appear before the Committee.

 

This could happen as soon as 10 February and requests to appear could happen with little advance warning.

 

The MTAA has already started drafting its submission.

 

This Senate inquiry will be critical for the industry as it will start at the beginning of 2017 and has the potential for flow on impact throughout 2017 as the new revamped PLAC continues to work through the Industry Working Group report.

 

The MTAA is happy to assist and discuss with members and non-members if they have any questions about the Senate Inquiry, please contact Polo Guilbert-Wright – polo@mtaa.org.au

 

Image

CSIRO Roadmaps

CSIRO is producing a series of five roadmaps each aligned to the Federal Government’s Industry Growth Centres. The first for the Advanced Manufacturing Sector was released last week.

 

In the roadmap CSIRO have touched on a number of key science and technology areas that relate to the MedTech industry. These include:

  • sensors and data analytics
  • advanced materials
  • smart robotics and automation
  • additive manufacturing (3D printing)
  • augmented and virtual reality. 

A copy of the report can be found here.

External Opportunities

 
 

P (+612) 9900 0600

F (+612) 9900 0655

E Reception@mtaa.org.au

 Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.


© 2016 Medical Technology Association of Australia, All rights reserved.
This e-mail is for the use of the intended recipient(s) only. If you have received this e-mail in error, please notify the sender immediately and then delete it. If you are not the intended recipient, you must not use, disclose or distribute this e-mail without the author's permission.